<h1>Abbreviations:</h1> EBoA , Enlarged Board of Appeal of the EPO, EUCJ , European Union Court of Justice; EPC , European Patent Convention; EPO , European Patent Office; EPOrg , European Patent Organisation The patent system has evolved over many centuries and has proven successful in stimulating innovation that is of benefit to society, or as Abraham Lincoln put it: “The patent system added the fuel of interest to the fire of genius.” Patents on microorganisms, such as baker's yeast, were already granted in the 19 th century; however, only at the end of the 20 th century, with the rise of genetic engineering, was patent law applied more broadly to living organisms. Today, genetically modified microorganisms, plants and animals are patentable in many jurisdictions, including the US, Japan and Europe. Still, many intuitively reject the concept of “patents on life”. The recent public debate about synthetic biology and “artificial life” (e.g. Craig Venter's minimal genome bacterium) has reignited this discussion. Other areas where patents are in the spotlight are breeding methods for plants and animals as well as human embryonic stem cells. What is patentable in Europe and on what legal basis? How is the law keeping pace
/lp/wiley/from-bench-to-market-life-science-patents-in-europe-pWAaUsbRVN